In the panel of randomly selected seminomas and non-seminoma GCTs, we detected similarly low levels of GCM1 expression (median 0.3350% POLR2A and 0.7493% POLR2A, respectively, Fig. 6) that was not increased over the tumor-matched controls and non-GCT testes. The gene discussed is GCM1; the disease is seminoma.